• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

    10/31/23 9:15:37 AM ET
    $AIU
    $AMKR
    $ANVS
    $CDT
    Other Consumer Services
    Real Estate
    Semiconductors
    Technology
    Get the next $AIU alert in real time by email

    Gainers

    LumiraDx Limited (NASDAQ:LMDX) shares surged 38.8% to $0.1250 in pre-market trading. LumiraDX shares fell 25% on Monday after the company announced the receipt of the Nasdaq delisting determination.

    TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares gained 30.1% to $0.4682 in pre-market trading after the company announced it is withdrawing the underwritten public offering of its common stock.

    VS MEDIA Holdings Limited (NASDAQ:VSME) shares climbed 17% to $0.84 in pre-market trading after falling 8% on Monday.

    Pinterest, Inc. (NYSE:PINS) shares rose 16.5% to $29.25 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance.

    Wolfspeed, Inc. (NYSE:WOLF) rose 14.9% to $31.85 in pre-market trading after the company reported first-quarter earnings.

    NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) shares rose 13.8% to $0.97 in pre-market trading after gaining 11% on Monday.

    Electriq Power Holdings, Inc. (NYSE:ELIQ) shares rose 13% to $0.8499 in pre-market trading after falling more than 8% on Monday.

    Meta Data Limited (NYSE:AIU) shares jumped 12% to $1.12 in pre-market trading.

    Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) rose 11.4% to $0.5180 in pre-market trading. On Oct. 24, 2023, Shuttle Pharmaceuticals entered into an exclusive licensing agreement with Georgetown University.

    HomeStreet, Inc. (NASDAQ:HMST) gained 10.5% to $5.05 in pre-market trading following better-than-expected third-quarter earnings.

    Losers

    Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares fell 45.4% to $58.82 in pre-market trading as the company reported topline results from EMBARK, a global pivotal study of ELEVIDYS gene therapy for Duchenne Muscular Dystrophy.

    PetMed Express, Inc. (NASDAQ:PETS) dipped 26.8% to $6.72 in pre-market trading after reporting weaker-than-expected second-quarter sales.

    Tempo Automation Holdings, Inc. (NASDAQ:TMPO) shares fell 20.9% to $0.0935 in pre-market trading. Tempo Automation recently announced commencement of Nasdaq delisting proceedings.

    Lattice Semiconductor Corporation (NASDAQ:LSCC) shares fell 17.5% to $55.50 in pre-market trading after the company reported third-quarter financial results and issued weak sales forecast for the fourth quarter.

    Amkor Technology, Inc. (NASDAQ:AMKR) shares fell 16.8% to $17.00 in pre-market trading after the company reported a year-over-year decrease in third-quarter EPS results and issued Q4 revenue guidance below estimates.

    Annovis Bio, Inc. (NYSE:ANVS) shares fell 9.2% to $7.40 in pre-market trading after the company announced launch of a proposed public offering.

    MicroCloud Hologram Inc. (NASDAQ:HOLO) shares fell 8.6% to $0.7123 in pre-market trading after surging around 38% on Monday.

    Conduit Pharmaceuticals Inc. (NASDAQ:CDT) fell 8.3% to $1.44 in pre-market trading after jumping around 54% on Monday.

    Orgenesis Inc. (NASDAQ:ORGS) fell 8% to $0.7454 in pre-market. Orgenesis announced withdrawal of its earlier announced proposed underwritten public offering due to market conditions.

    V.F. Corporation (NYSE:VFC) shares fell 7.9% to $15.76 in pre-market trading after the company reported downbeat second-quarter earnings and withdrew its full-year guidance.

    Now Read This: Pfizer, AMD And 3 Stocks To Watch Heading Into Tuesday

    Get the next $AIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIU
    $AMKR
    $ANVS
    $CDT

    CompanyDatePrice TargetRatingAnalyst
    Pinterest Inc.
    $PINS
    3/2/2026Buy → Hold
    Argus
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Pinterest Inc.
    $PINS
    2/13/2026$16.00Buy → Hold
    Deutsche Bank
    Pinterest Inc.
    $PINS
    2/13/2026$17.00Outperform → Sector Perform
    RBC Capital Mkts
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Outperform → Neutral
    Robert W. Baird
    Pinterest Inc.
    $PINS
    2/13/2026$19.00Buy → Neutral
    Citigroup
    Pinterest Inc.
    $PINS
    2/13/2026$19.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $AIU
    $AMKR
    $ANVS
    $CDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hoffman Michael B bought $193,794 worth of shares (45,000 units at $4.31), increasing direct ownership by 2% to 2,574,739 units (SEC Form 4)

    4 - Annovis Bio, Inc. (0001477845) (Issuer)

    12/8/25 8:05:14 PM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Director Hoffman Michael B bought $159,886 worth of shares (39,200 units at $4.08), increasing direct ownership by 2% to 2,529,739 units (SEC Form 4)

    4/A - Annovis Bio, Inc. (0001477845) (Issuer)

    11/25/25 6:59:54 PM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hoffman Michael B bought $159,886 worth of shares (39,200 units at $4.08), increasing direct ownership by 2% to 2,519,739 units (SEC Form 4)

    4 - Annovis Bio, Inc. (0001477845) (Issuer)

    11/25/25 12:26:46 PM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIU
    $AMKR
    $ANVS
    $CDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Estepan Ian Michael covered exercise/tax liability with 1,097 shares, decreasing direct ownership by 0.54% to 201,983 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    3/13/26 8:09:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Wong Ryan Ho-Yan covered exercise/tax liability with 256 shares, decreasing direct ownership by 0.19% to 135,064 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    3/13/26 8:07:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President, R&D and Tech Ops Rodino-Klapac Louise covered exercise/tax liability with 948 shares, decreasing direct ownership by 0.42% to 225,323 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    3/13/26 8:05:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIU
    $AMKR
    $ANVS
    $CDT
    SEC Filings

    View All

    SEC Form 10-K filed by Annovis Bio Inc.

    10-K - Annovis Bio, Inc. (0001477845) (Filer)

    3/13/26 5:15:44 PM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Orgenesis Inc. filed SEC Form 8-K: Leadership Update

    8-K - Orgenesis Inc. (0001460602) (Filer)

    3/13/26 3:48:44 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Lattice Semiconductor Corporation

    8-K - LATTICE SEMICONDUCTOR CORP (0000855658) (Filer)

    3/11/26 4:37:28 PM ET
    $LSCC
    Semiconductors
    Technology

    $AIU
    $AMKR
    $ANVS
    $CDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIU
    $AMKR
    $ANVS
    $CDT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wolfspeed Appoints Silicon Carbide Industry Veteran Daihui Yu as Regional President, Greater China

    Wolfspeed is pleased to announce the appointment of Daihui Yu as regional president for Greater China, effective March 16, 2026. In this key leadership position, Yu will oversee the expansion of the company's business across mainland China, Hong Kong and Taiwan, utilizing his substantial expertise to drive sales growth and strengthen our brand presence in the region. Yu holds a degree in electrical engineering from Wuhan University of Technology and an MBA from Tsinghua University. Prior to joining Wolfspeed, Yu served more than 12 years with Infineon Technologies as senior vice president and head of infrastructure and industry business for Greater China, managing regional sales and mar

    3/13/26 8:00:00 AM ET
    $WOLF
    Semiconductors
    Technology

    MicroCloud Hologram Inc. (NASDAQ: HOLO) 2025 Annual Performance Forecast: Investment Income Fluctuations Lead to Annual Loss, Core Business Maintains Steady Growth

    SHENZHEN, China, March 13, 2026 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ:HOLO), ("HOLO" or the "Company"), a technology service provider, has made an initial estimate through its financial department, predicting that the net profit attributable to shareholders of the listed Company for the year 2025 will show a loss compared to the same period last year. Explanation of MicroCloud Hologram Inc.'s Performance Variations: Fluctuations in Financial Asset Investment Income: During this reporting period, the Company experienced investment losses due to changes in the fair value of certain financial assets and investment management activities.Core Business Remains Stable: The Compan

    3/13/26 8:00:00 AM ET
    $HOLO
    Computer Software: Programming Data Processing
    Technology

    CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 12, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the expansion of its proprietary AI Signature Agent platform through the curation of a rare disease signature database. Sarborg announced that it has curated a database containing approximately 1,700 rare disease signatures, building upon its existing disease signature library of more than 1,600 conditions, as well as its agrochemical and bacterial signature datasets previously announced. According to Sarborg, structuring rare diseases as machine-interpretable biological signatures enables rapid an

    3/12/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIU
    $AMKR
    $ANVS
    $CDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Pinterest downgraded by Argus

    Argus downgraded Pinterest from Buy to Hold

    3/2/26 8:00:47 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    V.F. Corp downgraded by Analyst with a new price target

    Analyst downgraded V.F. Corp from Neutral to Underweight and set a new price target of $18.00

    2/23/26 8:34:02 AM ET
    $VFC
    Garments and Clothing
    Industrials

    Pinterest downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Pinterest from Buy to Hold and set a new price target of $16.00

    2/13/26 10:37:47 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AIU
    $AMKR
    $ANVS
    $CDT
    Leadership Updates

    Live Leadership Updates

    View All

    Wolfspeed Appoints Silicon Carbide Industry Veteran Daihui Yu as Regional President, Greater China

    Wolfspeed is pleased to announce the appointment of Daihui Yu as regional president for Greater China, effective March 16, 2026. In this key leadership position, Yu will oversee the expansion of the company's business across mainland China, Hong Kong and Taiwan, utilizing his substantial expertise to drive sales growth and strengthen our brand presence in the region. Yu holds a degree in electrical engineering from Wuhan University of Technology and an MBA from Tsinghua University. Prior to joining Wolfspeed, Yu served more than 12 years with Infineon Technologies as senior vice president and head of infrastructure and industry business for Greater China, managing regional sales and mar

    3/13/26 8:00:00 AM ET
    $WOLF
    Semiconductors
    Technology

    Wolfspeed Strengthens Global Sales Leadership with Addition of Semiconductor Leader, Stefan Steyerl, as VP of Sales, EMEA

    Wolfspeed, Inc. (NYSE:WOLF), a global leader in silicon carbide technology and manufacturing, today announced the appointment of Stefan Steyerl as vice president of sales, EMEA. Effective March 1, 2026, Steyerl will develop and execute Wolfspeed's regional sales strategy, driving adoption of silicon carbide solutions across automotive, industrial, and energy markets as Wolfspeed accelerates the adoption of silicon carbide technology to expand its market footprint and deliver revenue growth across the region. Steyerl brings more than 25 years of experience in the semiconductor industry, with a proven track record of building high-performance teams and achieving revenue growth across global

    2/17/26 8:00:00 AM ET
    $WOLF
    Semiconductors
    Technology

    Pinterest Appoints Kecia Steelman to Board of Directors

    Pinterest, Inc. (NYSE:PINS) today announced that Kecia Steelman, President and Chief Executive Officer of Ulta Beauty, has been appointed to the company's Board of Directors, effective February 16, 2026. "Kecia is a seasoned executive with deep experience leading large-scale businesses and connecting consumers with brands they love," said Bill Ready, Chief Executive Officer of Pinterest. "Her track record of growing global businesses, building omnichannel experiences, and partnering closely with brands will be an asset as we continue to transform Pinterest into the leading visual discovery and AI-powered shopping platform, especially for Gen Z." Steelman joined Ulta Beauty in 2014 and h

    2/9/26 4:50:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $AIU
    $AMKR
    $ANVS
    $CDT
    Financials

    Live finance-specific insights

    View All

    Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments

    Net product revenues for the full year 2025 totaled $1,864.3 million, consisting of $965.6 million of PMO net product revenue and $898.7 million of ELEVIDYS net product revenue Net product revenues for the fourth quarter 2025 totaled $369.6 million, consisting of $259.2 million of PMO net product revenue and $110.4 million of ELEVIDYS net product revenue Following refinancing of 2027 notes and corporate restructuring, overall financial position and capital structure strengthened to support full investment in our pipeline and marketed therapies Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for

    2/25/26 4:05:00 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has entered into a strategic transaction to acquire a 20% equity stake in Sarborg Limited ("Sarborg"), an agentic AI signature intelligence business operating across multiple industrial sectors. The investment formalizes and deepens the existing collaboration between CDT and Sarborg, which has already supported the evaluation of CDT's clinical assets through Sarborg's proprietary signature analysis and artificial intelligence capabilities. Sarborg's business is built on the principle that biological, chemical and industrial signatures

    2/20/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amkor Technology Declares Quarterly Dividend

    Amkor Technology, Inc. (NASDAQ:AMKR), a leading provider of semiconductor packaging and test services, today announced that its Board of Directors has approved a quarterly cash dividend of $0.08352 per share on the company's common stock. The dividend will be payable on March 31, 2026 to stockholders of record as of the close of business on March 12, 2026. About Amkor Technology, Inc. Amkor Technology, Inc. (NASDAQ:AMKR) is the world's largest U.S. headquartered OSAT and is a global leader in outsourced semiconductor packaging and test services. With a strong track record of innovation, a broad and diverse geographic footprint and solid partnerships with lead customers, Amkor delivers h

    2/19/26 4:43:00 PM ET
    $AMKR
    Semiconductors
    Technology

    $AIU
    $AMKR
    $ANVS
    $CDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/6/24 11:56:48 AM ET
    $WOLF
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/5/24 2:20:23 PM ET
    $WOLF
    Semiconductors
    Technology